Schedule 13G ownership disclosure

TRAWS PHARMA INC

Common · CUSIP: 68232V884

Event date: 2026-01-14

Filing-level shares
543,268.00
Percent of class
6.8%
  • Chernett Jorey

    Shares: 543,268.00 · Class: 6.8%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0002042077-26-000007
Form type
SCHEDULE 13G
Filer
Chernett Jorey
CIK
CIK 2042077
Filed
Jan 16, 2026
Reporting period
Jan 14, 2026
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub